Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-13T05:09:52.201Z Has data issue: false hasContentIssue false

Public Interest in Myocarditis during the SARS-CoV-2 Pandemic

Published online by Cambridge University Press:  13 March 2023

Del Perkins*
Affiliation:
Oklahoma State University College of Osteopathic Medicine at Cherokee Nation, Office of Medical Student Research, Tahlequah, Oklahoma, USA
Rachel Wilkins
Affiliation:
Oklahoma State University College of Osteopathic Medicine at Cherokee Nation, Office of Medical Student Research, Tahlequah, Oklahoma, USA
Randi Kerr
Affiliation:
Oklahoma State University College of Osteopathic Medicine at Cherokee Nation, Office of Medical Student Research, Tahlequah, Oklahoma, USA
Benjamin Greiner
Affiliation:
University of Texas Medical Branch at Galveston, Department of Internal Medicine, Galveston, Texas, USA
Micah Hartwell
Affiliation:
Oklahoma State University College of Osteopathic Medicine at Cherokee Nation, Office of Medical Student Research, Tahlequah, Oklahoma, USAOklahoma State University Center for Health Sciences, Department of Psychiatry and Behavioral Sciences, Tulsa, Oklahoma, USA
*
Corresponding author: Del Perkins, Email: del.perkins@okstate.edu.
Rights & Permissions [Opens in a new window]

Abstract

Objective:

Public interest in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines has been rising with regard to associated myocarditis. Thus, the objective of our study was to assess trends in public interest in myocarditis during the course of the pandemic and the SARS-CoV-2 vaccine rollout in the United States.

Methods:

We conducted a longitudinal assessment of public interest in myocarditis, and its association with actual coronavirus disease 2019 (COVID-19) -related myocarditis during the first wave of the pandemic and SARS-CoV-2 vaccine-related myocarditis following vaccine rollout. To complete this objective, we used data from 3 sources: a report from the Morbidity and Mortality Weekly Report, the Vaccine Adverse Event Reporting database, and from Google Trends.

Results:

Results show that Relative Search Interest (RSI) was low before and during the initial phase of the pandemic and peaked in April 2021, during the initial vaccine push. The ratio of myocarditis related to the SARS-CoV-2 vaccines was considerably lower than the ratio of myocarditis from natural infection.

Conclusions:

Search interest in myocarditis was low until SARS-CoV-2 vaccines were rolled out, in which media coverage intensely focused on a relatively small number of cases. This study highlights both the benefits of COVID-19 vaccine uptake and the impact of the media on public interest

Information

Type
Original Research
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.
Figure 0

Figure 1.Comparison of the RSI for myocarditis throughout the SARS-CoV-2 pandemic with the number of reported vaccine-related myocarditis cases and the number of estimated COVID-19 myocarditis cases.

Figure 1

Figure 2.RSI for myocarditis throughout the SARS-CoV-2 pandemic compared to the ratio of myocarditis to COVID-19 cases and the ratio of vaccine-related myocarditis to vaccines given.